Rinder H M, Snyder E L
Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut.
Blood Cells. 1992;18(3):445-56; discussion 457-60.
This review will discuss how stored platelets become activated and will examine their ability to function and survive in vivo, posttransfusion. Experimental methods which have been shown to alter platelets during storage will be detailed. Using beta-thromboglobulin (beta-TG) and surface adhesion receptors as markers, investigators have examined the activation changes in platelet concentrates during preparation and storage. Resuspension of the platelet pellet after isolation of platelet-rich plasma appears to play a major role in producing platelet activation and beta-TG release during preparation. However, there is a significant amount of interdonor variability in platelet activation even at this early stage of storage. Over 5 days of storage, platelets release approximately 50% of their beta-TG contents. Furthermore, between 40% and 60% of the platelets express the alpha-granule membrane protein, P-selectin (GMP-140), during storage, which is also indicative of platelet activation. These activation changes correlate to some degree with platelet recovery posttransfusion but clearly do not explain the full lesion of platelet storage. The surface density of two platelet membrane receptors, glycoproteins (GP) Ib and IIb/IIIa, also change with activation, although in opposite directions. Platelet surface GPIb decreases initially with storage and then recovers, perhaps due to its relocation to the platelet surface from an intracellular pool. In contrast to GPIb, mean platelet surface GPIIb/IIIa increases slightly during storage, probably as a consequence of platelet activation and release of alpha-granule GPIIb/IIIa to the surface. Some hypotheses are offered regarding how these activated platelets can continue to circulate after transfusion. Further exploration of the platelet storage lesion will hopefully provide needed answers and thus permit better treatment of hemostatic disorders in the future.
本综述将讨论储存的血小板如何被激活,并研究其在输血后体内发挥功能和存活的能力。已证明在储存过程中会改变血小板的实验方法将详细介绍。研究人员以β-血小板球蛋白(β-TG)和表面黏附受体作为标志物,检测了血小板浓缩物在制备和储存过程中的激活变化。在富血小板血浆分离后对血小板沉淀进行重悬,似乎在制备过程中血小板激活和β-TG释放方面起主要作用。然而,即使在储存的这个早期阶段,不同献血者的血小板激活存在显著差异。在储存5天以上的时间里,血小板释放其约50%的β-TG含量。此外,在储存期间,40%至60%的血小板表达α-颗粒膜蛋白P-选择素(GMP-140),这也表明血小板被激活。这些激活变化在一定程度上与输血后血小板的恢复相关,但显然无法完全解释血小板储存损伤。两种血小板膜受体糖蛋白(GP)Ib和IIb/IIIa的表面密度也随激活而变化,尽管变化方向相反。血小板表面GPIb最初随储存而降低,然后恢复,这可能是由于它从细胞内池重新定位到血小板表面。与GPIb相反,储存期间血小板表面平均GPIIb/IIIa略有增加,这可能是血小板激活以及α-颗粒GPIIb/IIIa释放到表面的结果。关于这些激活的血小板在输血后如何继续循环,提出了一些假设。对血小板储存损伤的进一步探索有望提供所需答案,从而在未来更好地治疗止血障碍。